Another drug used as a possible treatment for seizures involving Dravet syndrome and CDKL5 deficiency disorder is ataluren, a drug whose main action is for preterm infants, allowing for the reading of the ribosome of an mRNA with the para codon generated in a full-length protein [117]. The gene discussed is CDKL5; the disease is Dravet syndrome.